97.82
price up icon2.62%   2.50
after-market Dopo l'orario di chiusura: 92.49 -5.33 -5.45%
loading

Incyte Corp Borsa (INCY) Ultime notizie

pulisher
Apr 17, 2026

Incyte Corp. stock outperforms competitors on strong trading day - MarketWatch

Apr 17, 2026
pulisher
Apr 17, 2026

INCYTE (NASDAQ: INCY) CEO granted 125,000 performance-based common shares - Stock Titan

Apr 17, 2026
pulisher
Apr 17, 2026

INCYTE (INCY) R&D president earns 27,892 performance shares in equity award - Stock Titan

Apr 17, 2026
pulisher
Apr 17, 2026

Incyte (NASDAQ: INCY) CMO earns 39,049 performance-based share award - Stock Titan

Apr 17, 2026
pulisher
Apr 17, 2026

INCY (NASDAQ: INCY) Form 144 lists 18,667-share option exercise and prior sales - Stock Titan

Apr 17, 2026
pulisher
Apr 16, 2026

Incyte Corp. stock outperforms competitors despite losses on the day - MarketWatch

Apr 16, 2026
pulisher
Apr 16, 2026

Incyte Shares Dip as Major Investor Reduces Stake - National Today

Apr 16, 2026
pulisher
Apr 16, 2026

Incyte Corporation $INCY Holdings Lowered by Massachusetts Financial Services Co. MA - MarketBeat

Apr 16, 2026
pulisher
Apr 15, 2026

Do Options Traders Know Something About Incyte Stock We Don't? - Yahoo Finance

Apr 15, 2026
pulisher
Apr 15, 2026

INCY Reiterates by HC Wainwright & Co. -- Price Target Maintained at $135 - GuruFocus

Apr 15, 2026
pulisher
Apr 15, 2026

H.C. Wainwright reiterates Incyte stock rating on hidradenitis drug - Investing.com

Apr 15, 2026
pulisher
Apr 15, 2026

Incyte's (INCY) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Apr 15, 2026
pulisher
Apr 15, 2026

28,383 Shares in Incyte Corporation $INCY Purchased by Monument Capital Management - MarketBeat

Apr 15, 2026
pulisher
Apr 15, 2026

Here's What to Expect From Incyte’s Next Earnings Report - Yahoo Finance

Apr 15, 2026
pulisher
Apr 12, 2026

Robeco Institutional Asset Management B.V. Increases Stake in Incyte Corporation $INCY - MarketBeat

Apr 12, 2026
pulisher
Apr 12, 2026

Beacon Harbor Wealth Advisors Boosts Incyte Corporation Holdings - National Today

Apr 12, 2026
pulisher
Apr 11, 2026

INCYTE CORP (NASDAQ:INCY) Presents a High-Growth Momentum Breakout Setup - ChartMill

Apr 11, 2026
pulisher
Apr 11, 2026

Q4 2025 Incyte Corp Earnings Call Transcript - GuruFocus

Apr 11, 2026
pulisher
Apr 10, 2026

Incyte Corp stock: What investors should know about its biotech potential now - AD HOC NEWS

Apr 10, 2026
pulisher
Apr 10, 2026

Incyte to Report First Quarter 2026 Financial Results - National Today

Apr 10, 2026
pulisher
Apr 09, 2026

L2 Asset Management, LLC's Incyte Corp(INCY) Holding History - GuruFocus

Apr 09, 2026
pulisher
Apr 09, 2026

Incyte Corporation (INCY) stock price, news, quote and history - Yahoo Finance UK

Apr 09, 2026
pulisher
Apr 09, 2026

Incyte to Report First Quarter Financial Results - Business Wire

Apr 09, 2026
pulisher
Apr 09, 2026

Incyte to post Q1 results at 7 a.m., host webcast April 28 - Stock Titan

Apr 09, 2026
pulisher
Apr 08, 2026

Barclays Maintains Overweight on Incyte Corporation (INCY) March 24, 2026 - Meyka

Apr 08, 2026
pulisher
Apr 08, 2026

Incyte Corp. stock rises Wednesday, still underperforms market - MarketWatch

Apr 08, 2026
pulisher
Apr 08, 2026

INCY Technical Analysis | Trend, Signals & Chart Patterns | INCYTE CORP (NASDAQ:INCY) - ChartMill

Apr 08, 2026
pulisher
Apr 07, 2026

Incyte Corporation (INCY) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 07, 2026
pulisher
Apr 07, 2026

Incyte Drug Shows Reduced COPD-like HS Flares in Phase III Data - MyChesCo

Apr 07, 2026
pulisher
Apr 07, 2026

Hidradenitis Suppurativa Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | InflaRx, Novartis, UCB, AbbVie, Pfizer, Amgen, Incyte Corp, CSL - Barchart.com

Apr 07, 2026
pulisher
Apr 07, 2026

Incyte Names Cagnoni President, Announces Leadership Changes - MyChesCo

Apr 07, 2026
pulisher
Apr 06, 2026

Incyte Corp. stock underperforms Monday when compared to competitors - MarketWatch

Apr 06, 2026
pulisher
Apr 06, 2026

Incyte Corp. (INCY) reports Q4 2025 revenue growth of 28% to $1.51B driven by Jakafi and Opzelura sales - MSN

Apr 06, 2026
pulisher
Apr 05, 2026

Allspring Global Investments Holdings LLC Buys 112,736 Shares of Incyte Corporation $INCY - MarketBeat

Apr 05, 2026
pulisher
Apr 05, 2026

Incyte (INCY) Is Up 6.2% After Positive Povorcitinib Data And New Oncology CollaborationHas The Bull Case Changed? - Yahoo Finance

Apr 05, 2026
pulisher
Apr 04, 2026

Toth Financial Advisory Corp Acquires Shares of 12,280 Incyte Corporation $INCY - MarketBeat

Apr 04, 2026
pulisher
Apr 03, 2026

Non Muscle Invasive Bladder Cancer Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Aura Biosciences, Protara Therapeutics, Vaxiion Therapeutics, Incyte Corp - Barchart

Apr 03, 2026
pulisher
Apr 03, 2026

Non Muscle Invasive Bladder Cancer Pipeline 2026: Key - openPR.com

Apr 03, 2026
pulisher
Apr 03, 2026

Incyte reports strong 54-week data from late-stage skin disorder study - MSN

Apr 03, 2026
pulisher
Apr 02, 2026

Adagene reveals Incyte deal, data update and public offering - The Pharma Letter

Apr 02, 2026
pulisher
Apr 02, 2026

Incyte Corp (INCY) board rep logs 421-share RSU fee grant - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Incyte (INCY) director Edmund Harrigan takes 269-share grant in fees - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Incyte (INCY) director takes 265-share board fee in stock - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC) - Yahoo Finance

Apr 02, 2026
pulisher
Apr 02, 2026

Citizens reiterates Incyte stock rating on pipeline progress By Investing.com - Investing.com South Africa

Apr 02, 2026
pulisher
Apr 02, 2026

Citizens reiterates Incyte stock rating on pipeline progress - Investing.com

Apr 02, 2026
pulisher
Apr 02, 2026

J. Safra Sarasin Holding AG Decreases Stake in Incyte Corporation $INCY - MarketBeat

Apr 02, 2026
pulisher
Apr 01, 2026

Barclays Maintains Overweight on Incyte (INCY) Mar 2026 - Meyka

Apr 01, 2026
pulisher
Mar 31, 2026

Incyte Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Mar 31, 2026
pulisher
Mar 31, 2026

Incyte Corp (INCY) Price Target Hiked at UBS on Sales and Earnings Growth Prospects - MSN

Mar 31, 2026
$29.83
price up icon 2.19%
$50.00
price up icon 3.14%
$102.92
price up icon 0.78%
$148.63
price down icon 0.43%
$144.48
price up icon 1.18%
ONC ONC
$323.87
price up icon 0.99%
Capitalizzazione:     |  Volume (24 ore):